ABSTRACT
Introduction. La fréquence, la présentation et le devenir de cardiomyopathie du peripartum (CMPP) varient considérablement dans le monde. Au Niger, les données sont inexistantes d'où le but de notre étude qui était de préciser les aspects épidémiologiques, diagnostiques, thérapeutiques et évolutifs de la cardiomyopathie du peripartum (CMPP). Méthodologie. Il s'agit d'une étude rétrospective concernant les patientes hospitalisées pour CMPPau pôle de Cardiologie de l'Hôpital National de Niamey du 01/01/2019 au 31/12/2019. Les facteurs de risque et les aspects épidémiologiques, cliniques, paracliniques, diagnostiques, thérapeutiques et évolutifs ont été étudiés. Résultats. La prévalence hospitalière de la CMPP était de 3,83%. L'âge moyen était de 27,4 ans (extrêmes de 16 et 45 ans). La multiparité a été rapportée chez 79 % des patientes contre 21% qui étaient primipares. La dyspnée était le signe le signe fonctionnel rapporté chez toutes les patientes. Les anomalies échocardiographiques les plus fréquentes étaient l'HVG (75%) et L'HAG (45,83%). L'hypocinésie était diffuse dans 100% des cas. L'altération de la fraction d'éjection du ventricule du ventricule gauche (FEVG) était moyenne dans 50%. Toutes les patientes ont ont eu comme traitement des bétabloquants, des diurétiques et des IEC. L'évolution a été favorable dans 87,5 % des cas. Les principaux facteurs pronostiques péjoratifs étaient la multiparité (79%) une fraction d'éjection du ventricule inférieure à (FEVG)
Introduction. The frequency, presentation and outcome of peripartum cardiomyopathy (PCM) vary considerably throughout the world. In Niger, data are non-existent, hence the aim of our study, which was to clarify the epidemiological, diagnostic, therapeutic and evolutionary aspects of peripartum cardiomyopathy (PPCM). Methodology. This is a retrospective study concerning patients hospitalized for CMPPat the Cardiology pole of the National Hospital of Niamey from 01/01/2019 to 31/12/2019. Risk factors and epidemiological, clinical, paraclinical, diagnostic, therapeutic and evolutionary aspects were studied. Results. The hospital prevalence of CMPP was 3.83%. The mean age was 27.4 years (extremes 16 and 45 years). Multiparity was reported in 79% of patients versus 21% who were primiparous. Dyspnea was the functional sign reported in all patients. The most frequent echocardiographic abnormalities were LVH (75%) and GAH (45.83%). Hypokinesia was diffuse in 100% of cases. Impaired left ventricular ejection fraction (LVEF) was moderate in 50%. All patients were treated with beta-blockers, diuretics and ACE inhibitors. Progression was favorable in 87.5% of cases. The main pejorative prognostic factors were multiparity (79%) lower ventricular ejection fraction (LVEF)
Subject(s)
Humans , Female , Peripartum Period , Cardiomyopathies , Epidemiology , DiagnosisABSTRACT
The application of superabsorbent polymers (SAPs) and/or biochars to stressed lands offer solutions to several critical ecological, energy and economic challenges posed by degraded lands due to human activities. These substances are like, 'artificial humus' as they are hydrophilic and contain carboxylic groups (SAPs) which enable them to bind cations and water and sequester carbon from air to reverse global warming (biochars). Several research studies using these substances point to their ability to increase the plant-available water in the soil which enables the plants to survive longer with water shortage, increase soil fertility and agricultural yields, improve soil structure, aeration and water penetration, reduce use of synthetic fertilisers and pesticides, reduce nitrous oxide and methane emission from soil, reduce nitrate and farm chemicals leaching into watersheds, convert green and brown wastes into valuable resources, and reduce the evapotranspiration rate of the plants. SAPs and biochars induce a significantly higher growth rate in plants; they bind heavy metals and mitigate their action on plants as well as mitigate the effects of salinity. This paper reviews what is known about these claims and considers the wider environmental implications of the adoption of these processess. The intention is not just to summarise the current knowledge but also to identify gaps that require further research.
Subject(s)
Charcoal/chemistry , Environmental Restoration and Remediation , Metals, Heavy/isolation & purification , Nitrates/isolation & purification , Pesticides/isolation & purification , Soil Pollutants/isolation & purification , Soil/chemistry , Agriculture , Carbon/chemistry , Humans , Metals, Heavy/chemistry , Nitrates/chemistry , Pesticides/chemistry , Plants/chemistry , Plants/metabolism , Soil Pollutants/chemistry , Water/chemistryABSTRACT
This report describes a case of hepatic alveolar echinococcosis. To our knowledge it is the first documented report of human alveolar echinococcosis in Morocco. Alveolar echinococcosis of the liver is a relatively rare, severe chronic parasitic disease. It is characterized by slow-growing cysts that progressively invade and destroy the liver parenchyma like liver cancer. The discussion presents an update of the clinical, histologic, and therapeutic features of alveolar echinococcosis based on the findings in this case report and a review of the literature.
Subject(s)
Echinococcosis, Hepatic/diagnosis , Humans , Male , Middle Aged , MoroccoABSTRACT
Intra-abdominal desmoplastic small round cell tumor is an extremely rare and aggressive neoplasm that predominantly occurs in young adult men; it has an uncertain histogenesis, and predominant or exclusive intra-abdominal localisation without visceral origin involvement. This tumor is characterized by its distinct morphology and its multiphenotypic differentiation. We report a case of an intra-abdominal desmoplastic round cell tumor in a 24 years old woman. In the light of this case, the clinical morphological immunohistochemical and molecular of this rare desease are revewed.
Subject(s)
Abdominal Neoplasms/pathology , Adult , Female , HumansABSTRACT
This report describes a case of hep atic alveolar echinococcosis. To our knowledge it is the first documented rep o rt of human alveolar echinococcosis in Morocco. Alveolar echinococcosis of the liver is a relatively rare; severe chronic parasitic disease. It is ch a ra c t e ri zed by slow - growing cysts that progre s s ive ly invade and destroy the liver pare n chyma like liver cancer. The discussion presents an update of the clinical; histologic; and therapeutic features of alveolar echinococcosis based on the findings in this case report and a review of the literature